Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Malaria Diagnostics: Global Market Size, Share & Trends Analysis by Technology, Region and Competitive Landscape - Forecast to 2025 - ResearchAndMarkets.com

Research and Markets
Posted on: 09 Nov 18

The "Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Rapid Diagnostic Tests, Microscopy, Molecular Diagnostic Tests), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global malaria diagnostics market size is expected to reach USD 888.77 million by 2025 expanding at a CAGR of 4.5% during the forecast period.

Rising cases of tropical diseases, developments in diagnostic techniques, and rising investments by local government and private firms are factors propelling the market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to factors such as changing climate, underdeveloped healthcare infrastructure, and lack of advanced treatment options.

Technological advancements in diagnostic testing has been crucial in disease management. Increasing number of government initiatives and R&D investments by market players are anticipated to fuel market potential in the near future. A large number of programs are being undertaken by major companies in order to reduce disease prevalence.

For instance, Novartis Malaria Initiative was aimed at facilitating malaria elimination and control. The company has provided treatment to 750 million people across 60 countries without any profit. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market growth.

Further key findings from the report suggest:

  • Microscopy segment held the largest revenue share in 2017 due to wide usage of microscopic examination for the detection of malarial parasite
  • Rapid Diagnostic Tests (RDTs) would gain a considerable market share in near future owing to ease of use, convenience, and faster diagnosis offered by this technique
  • Molecular diagnostic tests are expected to witness the highest CAGR during the forecast period owing to their highly sensitive nature, accuracy, and capability of detecting low parasite count
  • The Africa region led the global market in 2017 on account of high disease incidence and subsequent adoption of various malarial diagnostic techniques
  • South East Asia held a considerable market share in 2017 owing to high disease reoccurrence and presence of a number of initiatives undertaken for disease control
  • Key companies in the market are Access Bio, Inc.; Alere, Inc.; Premier Medical Corporation Ltd.; Sysmex Partec GmbH; bioMrieux, Inc.; Beckman Coulter, Inc.; Siemens Healthineers; and Leica Microsystems GmbH.

Key Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Malaria Diagnostics Market Variables, Trends & Scope

Chapter 4 Malaria Diagnostics Market: Technology Type Estimates & Trend Analysis

Chapter 5 Malaria Diagnostics Market: Regional Estimates & Trend Analysis, by Technology

Chapter 6 Competitive Landscape

  • Access Bio, Inc.
  • Abbott
  • Premier Medical Corporation Ltd.
  • Sysmex Partec GmbH
  • bioMerieux
  • Beckman Coulter, Inc.
  • Siemens Healthineers
  • Leica Microsystems GmbH
  • Nikon Corporation
  • Olympus Corporation
  • Bio-Rad Laboratories, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/rqnrfb/malaria?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181109005515/en/

Business Wire
www.businesswire.com

Last updated on: 09/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.